Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19

Stephenson, Kathryn E; Le Gars, Mathieu; Sadoff, Jerald; de Groot, Anne Marit; Heerwegh, Dirk; Truyers, Carla; Atyeo, Caroline; Loos, Carolin; Chandrashekar, Abishek; McMahan, Katherine; Tostanoski, Lisa H.; Yu, Jingyou; Gebre, Makda S.; Jacob-Dolan, Catherine; Li, Zhenfeng; Patel, Shivani; Peter, Lauren; Liu, Jinyan; Borducchi, Erica N.; Nkolola, Joseph P; Souza, Morgana Stefani de; Tan, Chen Sabrina; Zash, Rebecca; Julg, Boris; Nathavitharana, Ruvandhi R.; Shapiro, Roger L; Azim, Ahmed Abdul; Alonso, Carolyn D; Jaegle, Kate; Ansel, Jessica L; Kanjilal, Diane G; Guiney, Caitlin J.; Bradshaw, Connor; Tyler, Anna; Makoni, Tatenda; Yanosick, Katherine E; Seaman, Michael S.; Lauffenburger, Douglas A.; Alter, Galit; Struyf, Frank; Douoguih, Macaya; Van Hoof, Johan; Schuitemaker, Hanneke; Barouch, Dan H.

doi:10.1001/jama.2021.3645

Record: found
Abstract: not found
Article: not found

Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19

Author(s): Kathryn E. Stephenson ¹ ^, ² ^, ³ , Mathieu Le Gars ⁴ , Jerald Sadoff ⁴ , Anne Marit de Groot ⁴ , Dirk Heerwegh ⁵ , Carla Truyers ⁵ , Caroline Atyeo ² ^, ⁶ , Carolin Loos ² ^, ⁷ , Abishek Chandrashekar ¹ , Katherine McMahan ¹ , Lisa H. Tostanoski ¹ , Jingyou Yu ¹ , Makda S. Gebre ¹ ^, ⁶ , Catherine Jacob-Dolan ¹ ^, ⁶ , Zhenfeng Li ¹ , Shivani Patel ¹ , Lauren Peter ¹ , Jinyan Liu ¹ , Erica N. Borducchi ¹ , Joseph P. Nkolola ¹ , Morgana Souza ¹ , Chen Sabrina Tan ¹ ^, ³ , Rebecca Zash ¹ ^, ³ , Boris Julg ¹ ^, ² , Ruvandhi R. Nathavitharana ³ , Roger L. Shapiro ³ , Ahmed Abdul Azim ³ , Carolyn D. Alonso ³ , Kate Jaegle ¹ , Jessica L. Ansel ¹ , Diane G. Kanjilal ¹ , Caitlin J. Guiney ¹ , Connor Bradshaw ¹ , Anna Tyler ¹ , Tatenda Makoni ¹ , Katherine E. Yanosick ¹ , Michael S. Seaman ¹ , Douglas A. Lauffenburger ⁷ , Galit Alter ² , Frank Struyf ⁵ , Macaya Douoguih ⁴ , Johan Van Hoof ⁴ , Hanneke Schuitemaker ⁴ , Dan H. Barouch ¹ ^, ² ^, ³ ^, ⁶ ^, ⁸

Publication date (Electronic): March 11 2021

Journal: JAMA

Publisher: American Medical Association (AMA)

Read this article at

ScienceOpenPublisher PMC

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

<p class="first" id="d21347804e487">Control of the global COVID-19 pandemic will require the development and deployment of safe and effective vaccines. </p>

Related collections

Author and article information

Journal

Title: JAMA

Abbreviated Title: JAMA

Publisher: American Medical Association (AMA)

ISSN (Print): 0098-7484

Publication date (Electronic): March 11 2021

Affiliations

[1 ]Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts

[2 ]Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts

[3 ]Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts

[4 ]Janssen Vaccines & Prevention, Leiden, the Netherlands

[5 ]Janssen Research & Development, Beerse, Belgium

[6 ]Harvard Medical School, Boston, Massachusetts

[7 ]Massachusetts Institute of Technology, Cambridge

[8 ]Massachusetts Consortium on Pathogen Readiness, Boston

Article

DOI: 10.1001/jama.2021.3645

PMC ID: 7953339

PubMed ID: 33704352

SO-VID: 2232250f-68c4-4ac8-86f4-4944f505395d

History

Data availability:

Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19

Read this article at

Abstract

Related collections

Novel Coronavirus Disease COVID-19

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 5,039

Cited by 144